Bradley Merrill Thompson, Member of the Firm in the Health Care & Life Sciences practice, in the firm’s Washington, DC, office, was cited in MobiHealthNews, in “A Closer Look at the FDA’s Moves, Clearances in the Second Half of 2019,” by Dave Muoio and Laura Lovett.

Following is an excerpt:

The back half of 2019 saw an FDA in the midst of a transition — both in terms of personnel and in digital regulation strategy. …

And while many eyes will be on high-profile health issues such as underage vaping and the opioid epidemic, those with an interest in digital health will be keen to see the agency’s ongoing efforts to revamp the regulation of these novel products.

Take, for instance, the FDA’s Pre-Cert Program. Early in the second half of 2019 the agency released a Mid-Year Update of the program’s Working Model one-year pilot. At the time, the agency reported that its retrospective testing of the original nine pilot participants was complete and that prospective testing was in progress. Not too long afterward, pilot participant Pear Therapeutics announced that Somryst, its experimental digital treatment for chronic insomnia and depression, would be the first software as a medical device product to be submitted for marketing approval through the novel pathway.

The FDA is still on the hook for an end-of-year update on the pilot program’s progress, but the past couple of months have had certain onlookers questioning Pre-Cert’s unique approach to regulation. At the end of October, Senators Elizabeth Warren, Patty Murray and Tina Smith penned an open letter to the agency expressing concern over the program’s potential impact on public safety. Some of these points were echoed in an op-ed by regulatory law expert and industry spokesperson Bradley Merrill Thompson, who also worried that precertification would come at the detriment of a lively startup environment.

Related reading:

November 1, 2019, MobiHealthNews, “Applying Data Science Principles to FDA’s PreCert Program: Some Scary Stuff,” by Bradley Merrill Thompson.

Jump to Page

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.